Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | R347* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | BRAF R347* results in a premature truncation of the Braf protein at amino acid 347 of 766 (UniProt.org). Due to the loss of a portion of the protein kinase domain (UniProt.org), R347* is predicted to lead to a loss of Braf protein function. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF inact mut BRAF R347* |
Transcript | NM_004333.6 |
gDNA | chr7:g.140794409G>A |
cDNA | c.1039C>T |
Protein | p.R347* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017012558 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001374244.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_047420767.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_047420768.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001378469.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_017012559.2 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001378471.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_017012559 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001378475.1 | chr7:g.140783031_140783032delAGinsTA | c.1039_1040delAGinsTA | p.R347* | RefSeq | GRCh38/hg38 |
NM_001374258.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_017012558.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_017012559.1 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140794409G>A | c.1039C>T | p.R347* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|